United States: Psychedelics & Drug Development — Key Considerations For Healthcare Industry And Life Sciences Companies As Congress Seeks To Tap Into Psychedelics' Therapeutic Potential - Goodwin Procter LLP
On March 8, 2023, US Sens. Cory Booker (D-NJ) and Rand Paul (R-KY) introduced an updated version of the Breakthrough Therapies Act, and US Reps. Nancy Mace (R-SC) and Madeleine Dean (D-PA) introduced companion legislation in the House.
Full Article